Blood loss (ml) Estimated blood loss during myomectomy · women with uterine fibroids
Ascorbic acid showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with no treatment to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Blood transfusion · women with uterine fibroids
It is very uncertain whether ascorbic acid changes need for blood transfusion Participants who received blood transfusion compared with no treatment to reduce blood loss during myomectomy (very low certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
Ascorbic acid showed no clear difference in duration of surgery (min) Operative time compared with no treatment to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Change in 10‐metre walking time · people with fatigue in peripheral neuropathy
1 finding from 1 review
Change in 9‐hole peg test (HPT) at 12 months (seconds) · people with fatigue in peripheral neuropathy
1 finding from 1 review
Health‐related quality of life (physical) · people with fatigue in peripheral neuropathy
1 finding from 1 review
Participation · people with fatigue in peripheral neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life (mental) · people with fatigue in peripheral neuropathy
1 finding from 1 review
Serious adverse events · people with fatigue in peripheral neuropathy
Ascorbic acid showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Reduction in fatigue · people with fatigue in peripheral neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · people with fatigue in peripheral neuropathy
1 finding from 1 review
Change in activity limitations · people with fatigue in peripheral neuropathy
1 finding from 1 review
Ascorbic acid · women with uterine fibroids
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in ascorbic acid compared with placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Impairment ‐ change in CMTNS at 24 months (0 to 36 points) · adults with CMT1A
1 finding from 1 review
Intervention not reported
Impairment ‐ change in CMTES at 24 months (0 to 28 points) · adults with CMT1A
1 finding from 1 review
Intervention not reported
Change in timed 10‐m walk at 12 months (seconds (s)) · adults with CMT1A
1 finding from 1 review
Intervention not reported
Change in foot dorsiflexion at 12 months (N) · adults with CMT1A
1 finding from 1 review
Intervention not reported
Change in 9‐hole peg test (HPT) at 12 months (seconds) · adults with CMT1A
1 finding from 1 review
Intervention not reported
Serious adverse events (SAE; %) · adults with CMT1A
1 finding from 1 review